Low Diversity and Instability of the Sinus Microbiota over Time in Adults with Cystic Fibrosis
Catherine R. Armbruster, Kelvin Li, Megan R. Kiedrowski, Anna C. Zemke, Jeffrey A. Melvin, John Allphin Moore, S. Atteih, Adam Fitch, Matthew DuPont, Christopher D. Manko, Madison L. Weaver, Jordon R. Gaston, John F. Alcorn, Alison Morris, Barbara A. Methé, Stella E. Lee, Jennifer M. Bomberger
Abstract
Together with prior sinus microbiota studies of adults with CF chronic rhinosinusitis, our study underscores similarities between sinus and lower respiratory tract microbial community structures in CF. We show how community structure tracks with inflammation and several disease measures. This work strongly suggests that clinical management of CRS could be leveraged to improve overall respiratory health in CF. Our work implicates elevated IL-1β in reduced microbiota diversity and worse sinus disease in CF CRS, suggesting applications for existing therapies targeting IL-1β. Finally, the widespread use of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy has led to less frequent availability of spontaneous expectorated sputum for microbiological surveillance of lung infections. A better understanding of CF sinus microbiology could provide a much-needed alternative site for monitoring respiratory infection status by important CF pathogens.